Hosted on MSN26d
Medifast (NYSE:MED) Surprises With Q4 Sales But Quarterly Revenue Guidance Significantly Misses ExpectationsIs now the time to buy Medifast? Find out by accessing our full research report, it’s free. ・Revenue: $119 million vs analyst estimates of $114.3 million (37.7% year-on-year decline, ...
Is Medifast a buy or sell going into earnings? Read our full analysis here, it’s free. This quarter, analysts are expecting Medifast’s revenue to decline 40.2% year on year to $114.3 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results